Abstract
We treated a patient with type 2 diabetes suffering from chronic venous and neuro-ischemic wounds not healing under standard care with local application of autologous bone marrow cells (mBMC) isolated from bone marrow aspirate. This procedure led to a reduction of wound size, a markedly increased vascularization and infiltration of mononuclear cells, 7 days after treatment, without any signs of a systemic reaction to treatment. Locally applied mBMC could, therefore, provide a treatment option in end stage diabetic wound healing disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 538-540 |
| Number of pages | 3 |
| Journal | Experimental and Clinical Endocrinology and Diabetes |
| Volume | 113 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Oct 2005 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords*
- Bone marrow cells
- Type 2 diabetes
- Wound healing
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
Fingerprint
Dive into the research topics of 'Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver